Recent session action on shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) puts the stock on today’s active list. Since the open, shares have moved 2.16% after recently hitting the $28.85 mark.
Digging a bit further, company shares have been noted -14.62% off the 52 week high and 1406.53% away from the 52 week low. Looking at a shorter time period, shares have been seen -14.62% away from the 50 day high and 256.17% off the 50 day low price.Covering sell-side analysts have recently weighed in on shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO). At the time of writing, the First Call consensus price target for the company is $16.00. The current consensus recommendation provided by covering analysts is 2.20. This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.
Since the beginning of the calendar year, the stock is 860.30%. For the quarter, shares have been noted at 295.14%. Share performance for the month is currently at 114.85%. Tightening the gaze, stock performance for the last 5 trading days is 107.12%.